269 related articles for article (PubMed ID: 22077150)
1. Hdac-mediated control of endochondral and intramembranous ossification.
Bradley EW; McGee-Lawrence ME; Westendorf JJ
Crit Rev Eukaryot Gene Expr; 2011; 21(2):101-13. PubMed ID: 22077150
[TBL] [Abstract][Full Text] [Related]
2. Histone Deacetylases in Bone Development and Skeletal Disorders.
Bradley EW; Carpio LR; van Wijnen AJ; McGee-Lawrence ME; Westendorf JJ
Physiol Rev; 2015 Oct; 95(4):1359-81. PubMed ID: 26378079
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.
Carpio LR; Bradley EW; McGee-Lawrence ME; Weivoda MM; Poston DD; Dudakovic A; Xu M; Tchkonia T; Kirkland JL; van Wijnen AJ; Oursler MJ; Westendorf JJ
Sci Signal; 2016 Aug; 9(440):ra79. PubMed ID: 27507649
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation.
Lee HW; Suh JH; Kim AY; Lee YS; Park SY; Kim JB
Mol Endocrinol; 2006 Oct; 20(10):2432-43. PubMed ID: 16728531
[TBL] [Abstract][Full Text] [Related]
7. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase co-repressor complex control of Runx2 and bone formation.
Jensen ED; Nair AK; Westendorf JJ
Crit Rev Eukaryot Gene Expr; 2007; 17(3):187-96. PubMed ID: 17725488
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.
Feigenson M; Shull LC; Taylor EL; Camilleri ET; Riester SM; van Wijnen AJ; Bradley EW; Westendorf JJ
J Bone Miner Res; 2017 Dec; 32(12):2453-2465. PubMed ID: 28782836
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation.
Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W
Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301
[TBL] [Abstract][Full Text] [Related]
11. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases in skeletal development and bone mass maintenance.
McGee-Lawrence ME; Westendorf JJ
Gene; 2011 Mar; 474(1-2):1-11. PubMed ID: 21185361
[TBL] [Abstract][Full Text] [Related]
13. Runx2, an inducer of osteoblast and chondrocyte differentiation.
Komori T
Histochem Cell Biol; 2018 Apr; 149(4):313-323. PubMed ID: 29356961
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Runx2 by Histone Deacetylases in Bone.
Vishal M; Ajeetha R; Keerthana R; Selvamurugan N
Curr Protein Pept Sci; 2016; 17(4):343-51. PubMed ID: 27072566
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases.
Faulkner B; Astleford K; Mansky KC
Molecules; 2019 Apr; 24(7):. PubMed ID: 30959867
[TBL] [Abstract][Full Text] [Related]
16. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.
Hesse E; Saito H; Kiviranta R; Correa D; Yamana K; Neff L; Toben D; Duda G; Atfi A; Geoffroy V; Horne WC; Baron R
J Cell Biol; 2010 Dec; 191(7):1271-83. PubMed ID: 21173110
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylases in control of skeletogenesis.
Westendorf JJ
J Cell Biochem; 2007 Oct; 102(2):332-40. PubMed ID: 17661352
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.
Vega RB; Matsuda K; Oh J; Barbosa AC; Yang X; Meadows E; McAnally J; Pomajzl C; Shelton JM; Richardson JA; Karsenty G; Olson EN
Cell; 2004 Nov; 119(4):555-66. PubMed ID: 15537544
[TBL] [Abstract][Full Text] [Related]
19. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
[TBL] [Abstract][Full Text] [Related]
20. Targeting Runx2 expression in hypertrophic chondrocytes impairs endochondral ossification during early skeletal development.
Ding M; Lu Y; Abbassi S; Li F; Li X; Song Y; Geoffroy V; Im HJ; Zheng Q
J Cell Physiol; 2012 Oct; 227(10):3446-56. PubMed ID: 22223437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
